A. Linnenbach

Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma

D. Cognetti, M. Tuluc, S. Gargano, 2024, Cancer medicine.

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma

J. Netterville, B. Leiby, A. Argiris, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer.

A. Luginbuhl, A. Bagaev, O. Kudryashova, 2024, Cancer cell.